Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2012
09/20/2012WO2012060790A3 Water dispersible cefpodoxime proxetil formulations
09/20/2012WO2011005295A8 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
09/20/2012US20120238998 Octanoate-reduced Human Albumin
09/20/2012US20120238642 Polymer Mechanical Damping Composites and Methods of Production
09/20/2012US20120238637 Isolated Extract of Walnuts, Method For Its Obtention And Its Use
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238631 Compositions comprising cyclohexylamines and aminoadamantanes
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238610 Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
09/20/2012US20120238591 Acyclovir formulations
09/20/2012US20120238583 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238566 Use of cell autophagy (type ii cell apoptosis) inhibitors
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238556 Crystalline methylthioninium chloride hydrates
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238543 Antiviral Compounds
09/20/2012US20120238539 Novel piperazine analogs as broad-spectrum influenza antivirals
09/20/2012US20120238538 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238522 Carotenoid-containing compositions and methods
09/20/2012US20120238501 Modulation Of Osteoclast Differentiation
09/20/2012US20120238491 Immunologically active lipopeptides and methods for use thereof
09/20/2012US20120238488 Compounds and methods for treating neoplasia
09/20/2012US20120238024 Anti-Microbial Biotherapeutic Agents: Alternatives to Conventional Pharmaceutical Antibiotics
09/20/2012US20120237972 Mammalian-type glycosylation in plants
09/20/2012US20120237627 Pharmaceutical composition for treating cutaneous burns
09/20/2012US20120237617 Use of nitrite salts in treating tissue damage
09/20/2012US20120237616 Stabilized hypohalous acid solutions
09/20/2012US20120237605 Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same
09/20/2012US20120237593 Formulations of Guanylate Cyclase C Agonists and Methods of Use
09/20/2012US20120237592 Endoplasmic reticulum targeting liposomes
09/20/2012US20120237585 Adhesive Composition For Carrying Therapeutic Agents As Delivery Vehicle On Coatings Applied To Vascular Grafts
09/20/2012US20120237584 Silver-containing antimicrobial articles and methods of manufacture
09/20/2012US20120237572 Antiviral composition comprising a sulfated polysaccharide
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237564 Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease
09/20/2012US20120237562 Antibiotic drug delivery and potentiation
09/20/2012US20120237559 Formulations and methods for treating rhinosinusitis
09/20/2012US20120237549 Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
09/20/2012US20120237547 Live attenuated rotavirus vaccine for oral administration
09/20/2012US20120237546 Compounds and compositions as tlr activity modulators
09/20/2012US20120237545 Assays for influenza virus hemagglutinins
09/20/2012US20120237543 Equine rhinitis vaccine
09/20/2012US20120237542 Multivalent pneumococcal polysaccharide-protein conjugate composition
09/20/2012US20120237537 Methods for producing an immune response to tuberculosis
09/20/2012US20120237536 Combination vaccines against respiratory tract diseases
09/20/2012US20120237535 Therapeutic Compositions For The Treatment of HPV-Induced Diseases
09/20/2012US20120237534 Hyr1 as a target for active and passive immunization against candida
09/20/2012US20120237531 Topoisomerase inhibitors
09/20/2012US20120237527 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
09/20/2012US20120237523 Neutralizing antibodies to hiv-1 and their use
09/20/2012US20120237519 Pestvirus species
09/20/2012US20120237516 Compositions and methods relating to anti-igf-1 receptor antibodies
09/20/2012US20120237515 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
09/20/2012US20120237510 Anti-NKG2A Antibodies and Uses Thereof
09/20/2012US20120237508 Fused amino pyridine as hsp90 inhibitors
09/20/2012US20120237501 Anti-HIV Peptides and Methods of Use Thereof
09/20/2012US20120237492 Treatment of submental fat
09/20/2012US20120237491 Phage derived antimicrobial activities
09/20/2012US20120237489 Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non-esterified fatty acid
09/20/2012US20120237480 2'allene-substituted nucleoside derivatives
09/20/2012US20120237478 Modulators of pharmacokinetic properties of therapeutics
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237457 Anti-bacterial oral care composition and method for producing the same
09/20/2012US20120237455 Oral compositions containing extracts of zizyphus joazeiro and related methods
09/20/2012US20120237452 Antiseptic Solution of Di(4-Chloro-Phenyldiguanido) Compound And Process Therefor
09/20/2012US20120237443 Functionalizing implantable devices with a poly (diol citrate) polymer
09/20/2012CA2829993A1 Antimicrobial agents
09/20/2012CA2829968A1 Compositions and methods for the therapy and diagnosis of influenza
09/20/2012CA2829960A1 Listeria-based adjuvants
09/20/2012CA2829939A1 Tricyclic gyrase inhibitors
09/19/2012EP2500349A1 Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections
09/19/2012EP2500023A1 Antibiotics composition comprising beta-lactam antibiotic, beta-lactamase inhibitor, and buffer component
09/19/2012EP2500022A1 Antibacterial agent for drug-resistant bacteria, method for screening for same, and use of same
09/19/2012EP2500021A1 Therapeutic uses of VX-950
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499127A1 Hepatitis c virus inhibitors
09/19/2012EP2498813A1 Actinobacillus suis antigens
09/19/2012EP2498811A1 Bacteremia-associated antigen from staphylococcus aureus
09/19/2012EP2498767A1 Treatment of microbial infections
09/19/2012EP2498751A2 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
09/19/2012CN202437739U Herba sarcandrae soft capsule
09/19/2012CN102686599A Phosphoramidate derivatives of nucleosides
09/19/2012CN102686566A New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
09/19/2012CN102686222A Pharmaceutical for oral delivery comprising MGBG and methods of treating disease
09/19/2012CN102676547A Fusion protein containing neutralizing epitope gene of C-terminal of encephalitis-B E protein and vaccine containing fusion protein
09/19/2012CN102676519A Micro ribonucleic acid (RNA) for inhibiting viral multiplication of porcine reproductive and respiratory syndrome and application thereof
09/19/2012CN102676490A Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof
09/19/2012CN102676471A Chicken IL-18 (Interleukin-18) and Newcastle disease virus HN (Hemagglutinin-neuraminidase) gene recombinant fusion protein and application
09/19/2012CN102676461A Method for producing virus-like particles by utilizing drosophila cells and application
09/19/2012CN102676421A Bordetella bronchiseptica gene deletion strain, vaccine prepared from Bordetella bronchiseptica gene deletion strain and application
09/19/2012CN102676419A Salmonella typhi gene deletion strain, vaccine prepared from salmonella typhi gene deletion strain and application
09/19/2012CN102676396A Paecilomyces tenuipes strain and application thereof
09/19/2012CN102675482A Method for comprehensively utilizing pear residues
09/19/2012CN102675471A Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
09/19/2012CN102675460A Anti-tumor necrosis factor alpha human-derived antibody
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1798